General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

pane 4 content

Over-the-Counter

Novartis OTC (Over-the-Counter) is a world leader in the research, development, production and marketing of self-medication products that do not require prescriptions. Our products are designed for in-home treatment and prevention of medical conditions and ailments to enhance health and improve life every day.

Novartis OTC has a robust portfolio of cough, cold, respiratory disease, digestive health and pain management medication as well as analgesics, skin care products, smoking-cessation treatments and mineral supplements.

Not all products or indications are available in all countries. Regulatory requirements in various countries limit the product information that we can provide. Please consult your physician about any medical condition or product.

  • Bufferin

    Pain reliever

    Available in Brazil, Canada, Japan, Mexico, Saudi Arabia and the United States

  • Excedrin

    Pain reliever

    Available in Brazil, Canada, Colombia, Ecuador, Egypt, Jordan, Mexico, Peru, Saudi Arabia, South Africa and the United States

  • Voltaren

    Anti-inflammatory

    Available as topical Voltaren Emulgel (ex-US), topical Voltaren Gel as a prescription product (US only), or Voltaren systematic formulations

    Available in Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Denmark, Ecuador, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Jordan, Mexico, Netherlands, North Africa, Norway, Pakistan, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States and Venezuela